Tumour-Infiltrating Clonal Haematopoiesis Increases the Risk of Recurrence or Death Among Patients with NSCLC and the Risk of Death From Any Cause Among Patients with Solid Tumours By Ogkologos - May 7, 2025 682 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the analysis of TRACERx and MSK-IMPACT studies Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Haematologic Toxicity Not Increased with Immunochemotherapy Combinations Over Chemotherapy Treatment for... December 9, 2020 European Lung Cancer Congress 2024 March 7, 2024 Coronavirus Vaccines and People with Cancer: A Q&A with Dr. Steven... February 10, 2021 Navigating Your Care During Long-Term Cancer Survivorship June 25, 2020 Load more HOT NEWS Jennifer Garner Shared A Video Of Her Mammogram Appointment Football Player Scores 8 Touchdowns the Day After His Mom Dies... Five Questions With…Jim. New analysis estimates over 21 million UK adults will be obese...
